In older people, higher dietary calcium intake may lower the risk of cardiovascular disease, but not of stroke and fracture, new research from South Korea suggests. The results will be presented in a poster Saturday, April 2, at ENDO 2016, the annual meeting of the Endocrine Society, in Boston.
A Paleolithic-type diet may help obese postmenopausal women lose weight, improve their circulating fatty acid profile and lower their future risk for diabetes and cardiovascular disease, new research reports. The study results will be presented in a poster Sunday, April 3, at ENDO 2016, the annual meeting of the Endocrine Society, in Boston.
New findings from large-scale studies of more than 3.6 million people who underwent screening for cardiovascular disease reveals that a person’s age and gender affects the prevalence of certain types of peripheral vascular diseases (PVD), and that diabetes is a major risk factor for developing these diseases, even in patients without heart disease.
In this first randomized clinical trial for intermediate-risk patients with severe, symptomatic AS, conducted by researchers in the Perelman School of Medicine at the University of Pennsylvania, in partnership with Edwards Lifesciences, the Cardiovascular Research Foundation, and 56 center across the United States and Canada, investigators found that TAVR with SAPIEN XT resulted in similar two-year clinical outcomes, as compared to surgical aortic valve replacement. The study – the PARTNER II Trial – was presented today at the American College of Cardiology 65th Annual Scientific Session in Chicago and simultaneously published online in The New England Journal of Medicine.
A new study from Intermountain Medical Center Heart Institute and Johns Hopkins Medical Center lends more evidence to the idea that it’s better to be shaped like a pear — with weight around the hips — as opposed to an apple — with weight around the abdomen.
More walkable neighborhoods, parks and public transit could all reduce your chance of becoming one of the 600 million adults who battle obesity worldwide, according to researchers at University of California, San Diego School of Medicine. The study, recently published online in The Lancet, found a neighborhood’s design plays a critical role in physical activity and could help reduce non-communicable diseases, such as obesity, diabetes and cardiovascular disease.
Epilepsy is a neurological disorder that causes seizures of many different types. Recent research from Japan has found that epileptic seizures can be more easily predicted by using an electrocardiogram to measure fluctuations in the heart rate than by measuring brain activity, because the monitoring device is easier to wear. By making more accurate predictions, it is possible to prevent injury or accident that may result from an epileptic seizure. This is a significant contribution toward the realization of a society where epileptic patients can live without worrying about sustaining injury from an unexpected seizure.
Loyola Medicine is enrolling patients in a landmark clinical trial of a new procedure to treat atrial fibrillation, in which a physician uses a tiny lasso to tie off a thumb-size pouch attached to the heart.
End-stage heart failure patients treated with stem cells harvested from their own bone marrow experienced 37 percent fewer cardiac events - including deaths and heart failure hospital admissions - than a placebo-controlled group, according to a new study. Results from ixCELL-DCM, the largest cell therapy clinical trial for treating heart failure to date, will be presented at the 2016 American College of Cardiology annual meeting and published online in The Lancet on April 4.
A Saint Louis University scientist, Jane McHowat, Ph.D., will study how smoking impacts cardiac health beyond injury to the body’s arteries by damaging the heart muscle itself.
The Cardiovascular Research Foundation (CRF) announced today that Daniel Burkhoff, MD, PhD, has returned to the organization as Director of Heart Failure, Hemodynamics and Circulatory Support in the CRF Clinical Trials Center (CTC).
Patients undergoing minimally invasive mitral valve repair or replacement (mini-MVR) have similar outcomes as patients undergoing conventional surgery and also experience shorter hospital stays and fewer blood transfusions
Cerebral cavernous malformations (CCMs) are clusters of dilated, thin-walled blood vessels in the brain that can cause stroke and seizures, yet exactly how they form is somewhat of a mystery. Now, researchers have discovered the molecular mechanism that underlies this common cerebrovascular disease.
PinnacleHealth CardioVascular Institute enrolled the first two patients in the United States in a randomized trial studying a heart valve to treat aortic valve disorders.
To understand how people can live longer throughout the world, researchers at University of California, San Diego School of Medicine have teamed up with colleagues at University of Rome La Sapienza to study a group of 300 citizens, all over 100 years old, living in a remote Italian village nestled between the ocean and mountains on the country’s coast.
Physicians and fellows from the Cardiovascular Research Foundation (CRF) will be presenting abstracts at the American College of Cardiology 65th Annual Scientific Session taking place April 2-4, 2016 at McCormick Place in Chicago, IL. They will be sharing the latest data on drug-eluting stents, imaging technologies, dual antiplatelet therapy, transcatheter aortic valve replacement, and bioresorbable vascular scaffolds.
According to the World Health Organization, 37 million people are living with HIV. Antiviral medications are used to control the disease and prevent its progression to AIDS. Although antivirals improve health and increase survival for people with HIV, their use also has been linked to the development of cardiovascular disease. Now, researchers at the University of Missouri School of Medicine have identified an enzyme that may reduce the risk of cardiovascular disease caused by HIV medications.
Nearly 1 million people in the United States receive coronary artery stents each year. Nearly all stent patients are expected to take dual antiplatelet therapy (DAPT) using the combination of aspirin and a second antiplatelet medication to prevent the formation of blood clots. Exactly how long patients should receive DAPT has been debatable.
Mount Sinai Researchers Demonstrate that Targeting Matricellular Protein CCN5 can Reverse Established Cardiac Fibrosis in Heart Failure Models
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right